Watch PRCT. Know when insiders buy.
One email the day a filing lands. Free.
PRCT
PROCEPT BioRobotics Corp
20.07
−0.67 −3.23%
USD · close Sep 10
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
40
WATCH · insiders 49, shorts 30
Insiders, 90 days
−$22K
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.1BP/E —DIV YIELD —FCF YIELD -7.39%REV TTM $337.3M +22.7%NET INCOME −$109.8MNET CASH $176.2M52W 16.69 – 39.57SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $94.5M | +19.3% | 66.0% | −$27.4M | −$26.9M | — | -0.47 | −$19.3M | $3M | −$22.2M | Aug 5 |
| Q1 2026 · Mar 31 | $83.1M | +20.2% | 64.9% | −$32.6M | −$31.6M | — | -0.56 | −$38.1M | $2.9M | −$41M | Aug 5 |
| Q4 2025 · Dec 31derived | $76.4M | +11.9% | 60.6% | −$31M | −$29.8M | — | -0.53 | −$10.3M | $1.9M | −$12.2M | Feb 26 |
| Q3 2025 · Sep 30 | $83.3M | +42.8% | 64.8% | −$23.2M | −$21.4M | — | -0.38 | −$6.6M | $2.9M | −$9.5M | Nov 5 |
| Q2 2025 · Jun 30 | $79.2M | +48.4% | 65.4% | −$22.2M | −$19.6M | — | -0.35 | −$15M | $2.8M | −$17.8M | Aug 5 |
| Q1 2025 · Mar 31 | $69.2M | +55.3% | 63.9% | −$27.4M | −$24.7M | — | -0.45 | −$17M | $1.8M | −$18.8M | Aug 5 |
| Q4 2024 · Dec 31derived | $68.2M | +56.6% | 64.0% | −$19.7M | −$18.9M | — | -0.34 | −$32.4M | $1.2M | −$33.6M | Feb 26 |
| Q3 2024 · Sep 30 | $58.4M | +66.3% | 63.2% | −$22.4M | −$21M | — | -0.40 | −$18.8M | $246K | −$19M | Nov 5 |
| Q2 2024 · Jun 30 | $53.4M | — | 59.0% | −$26.8M | −$25.6M | — | -0.50 | −$15.7M | $1M | −$16.8M | Nov 5 |
| Q1 2024 · Mar 31 | $44.5M | — | 56.2% | −$27.6M | −$26M | — | -0.51 | −$32.3M | $1.9M | −$34.2M | Nov 5 |
| Q4 2023 · Dec 31derived | $43.6M | — | 48.8% | −$29.6M | −$27.5M | — | -0.54 | −$24.8M | $8.7M | −$33.5M | Feb 26 |
| Q3 2023 · Sep 30 | $35.1M | — | 53.8% | −$25.6M | −$24.6M | — | -0.51 | −$18.9M | $5.8M | −$24.7M | Oct 28 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $308.1M | 63.7% | −$103.9M | −$95.6M | -31.0% | -1.72 | −$49M | $9.4M | −$58.3M | — | — |
| FY2024 · to Dec 31 | $224.5M | 61.1% | −$96.6M | −$91.4M | -40.7% | -1.75 | −$99.2M | $4.4M | −$103.6M | — | — |
| FY2023 · to Dec 31 | $136.2M | 52.2% | −$109.2M | −$105.9M | -77.8% | -2.24 | −$108M | $25.2M | −$133.2M | — | — |
| FY2022 · to Dec 31 | $75M | 49.4% | −$80.7M | −$87.2M | -116.2% | -1.96 | −$80.4M | $2.7M | −$83M | — | — |
| FY2021 · to Dec 31 | $34.5M | 46.0% | −$54.2M | −$59.9M | -173.6% | -3.63 | −$57.3M | $592K | −$57.9M | — | — |
| FY2020 · to Dec 31 | $7.7M | -16.3% | −$47.8M | −$53M | -687.0% | -14.47 | −$48.3M | $233K | −$48.6M | — | — |
Every number comes from PROCEPT BioRobotics Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.